A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
Clinical trial NCT02006628 · COMPLETED
Trial details
- NCT number
- NCT02006628
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-25
- Primary completion
- 2015-01-08
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.